BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24503355)

  • 1. Epidemiology of gastroesophageal reflux disease.
    Rubenstein JH; Chen JW
    Gastroenterol Clin North Am; 2014 Mar; 43(1):1-14. PubMed ID: 24503355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of the complications of gastroesophageal reflux disease.
    Belhocine K; Galmiche JP
    Dig Dis; 2009; 27(1):7-13. PubMed ID: 19439954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of esophageal adenocarcinoma.
    Pera M; Manterola C; Vidal O; Grande L
    J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection rate of the esophageaL GERD complications among residents of the Leningrad Region (according to the data of esophagogastroduodenoscopy tests)].
    Vasilevskiĭ DI; Silant'ev DS; Mikhaleva KV; Filin AV; Vorob'ev SL; Mednikov SN; Luft AV; Kulagin VI; Bagnenko SF
    Eksp Klin Gastroenterol; 2013; (5):12-6. PubMed ID: 24501940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GERD and its complications. The pathogenic relationship between symptoms and disease progression.
    Pisegna JR
    Postgrad Med; 2001 Oct; Spec No():19-23. PubMed ID: 11868427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis and epidemiology of Barrett esophagus].
    Spechler SJ
    Chirurg; 1994 Feb; 65(2):84-7. PubMed ID: 8162820
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States.
    Thukkani N; Sonnenberg A
    Aliment Pharmacol Ther; 2010 Apr; 31(8):852-61. PubMed ID: 20102354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux and adenocarcinoma of the esophagus.
    Nandurkar S; Talley NJ
    N Engl J Med; 1999 Aug; 341(7):536; author reply 537-8. PubMed ID: 10447437
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.
    Veugelers PJ; Porter GA; Guernsey DL; Casson AG
    Dis Esophagus; 2006; 19(5):321-8. PubMed ID: 16984526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations and complications of gastroesophageal reflux disease (GERD).
    Malfertheiner P; Hallerbäck B
    Int J Clin Pract; 2005 Mar; 59(3):346-55. PubMed ID: 15857335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in esophageal adenocarcinoma.
    Lagergren J; Lagergren P
    CA Cancer J Clin; 2013; 63(4):232-48. PubMed ID: 23818335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of environment and lifestyle on gastroesophageal reflux disease.
    Sonnenberg A
    Dig Dis; 2011; 29(2):229-34. PubMed ID: 21734389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
    Dixon JL; Copeland LA; Zeber JE; MacCarthy AA; Reznik SI; Smythe WR; Rascoe PA
    Dis Esophagus; 2016 Oct; 29(7):747-751. PubMed ID: 26455587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How is the gastroesophageal reflux disease prevalence, incidence, and frequency of complications (stricture/esophagitis/Barrett's esophagus/carcinoma) in Turkey compared to other geographical regions globally?
    Bor S; Sarıtaş Yüksel E
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S4-S9. PubMed ID: 29199158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.